163 related articles for article (PubMed ID: 370935)
1. [Recent progress in chemotherapy of multiple myeloma].
Tortarolo M; Cantore N; Russolillo S; Castaldo C; Buonanno G
Recenti Prog Med; 1978 Jul; 65(1):44-68. PubMed ID: 370935
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of multiple myeloma. Review of the recent trials].
Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
[No Abstract] [Full Text] [Related]
3. Remission maintenance therapy for multiple myeloma.
Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Kahler's disease].
Foa J; Carcassonne Y
Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
[No Abstract] [Full Text] [Related]
5. Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
Buonanno G; Tortarolo M; Valente A; Castaldo C; Russolillo S; Gonnella F
Haematologica; 1978 Feb; 63(1):45-55. PubMed ID: 417971
[No Abstract] [Full Text] [Related]
6. [Therapeutic experiences in multiple myeloma].
Sonntag R; Favre E; Martz G
Schweiz Med Wochenschr; 1972 Nov; 102(44):1588-9. PubMed ID: 4566555
[No Abstract] [Full Text] [Related]
7. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
[No Abstract] [Full Text] [Related]
8. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
[No Abstract] [Full Text] [Related]
10. [Survival and therapy of multiple myeloma. Apropos of 56 observed cases].
Locatelli F; Giovanelli E; Neretto G; Furno F; Pellerito R
Minerva Med; 1979 Mar; 70(13):925-33. PubMed ID: 220567
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell myeloma. An interpretive review.
Bergsagel DE
Cancer; 1972 Dec; 30(6):1588-94. PubMed ID: 4565818
[No Abstract] [Full Text] [Related]
12. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
13. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
Azam L; Delamore IW
Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
[No Abstract] [Full Text] [Related]
14. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
Abramson N; Lurie P; Mietlowski WL; Schilling A; Bennett JM; Horton J
Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
[TBL] [Abstract][Full Text] [Related]
15. [Combined cytostatic therapy of plasmacytoma].
Albert P; Zsuzsa M
Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
[No Abstract] [Full Text] [Related]
16. [Progress and results in the treatment of multiple myeloma].
Clauvel JP
Bull Cancer; 1972; 59(4):405-16. PubMed ID: 4592093
[No Abstract] [Full Text] [Related]
17. Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
Lee BJ; Sahakian G; Clarkson BD; Krakoff IH
Cancer; 1974 Feb; 33(2):533-8. PubMed ID: 4812771
[No Abstract] [Full Text] [Related]
18. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
19. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
Case DC; Lee DJ; Clarkson BD
Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
[No Abstract] [Full Text] [Related]
20. [Results of plasmacytoma therapy of ALGB (acute leukemia group B)].
Obrecht JP
Hamatol Bluttransfus; 1976; 18():383-93. PubMed ID: 964714
[No Abstract] [Full Text] [Related]
[Next] [New Search]